In your state
Missouri

In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

Economic Impact In Your State: Missouri

$19.2B

Total output supported by biophamaceutical sector

$587,029

Total output supported by biophamaceutical sector

78,688

Total Jobs

13,554

Direct Jobs

Clinical Trials in Your State: Missouri

970

TOTAL CLINICAL TRIALS

$354 million

INVESTED IN CLINICAL TRIALS

18,953

TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS

$981.1 million

INVESTED IN CLINICAL TRIALS

Programs and Initiatives in Your State: Missouri

State programs and initiatives to promote biopharmaceutical industry development

    ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT

    BUILDING RESEARCH CAPACITY AND/OR R&D INFRASTRUCTURE

    STEM EDUCATION & WORKFORCE DEVELOPMENT

    TARGETED STRATEGIES

    VENTURE FINANCING